Centre Hospitalier et Universitaire de Limoges

Limoges 87042

0 studies enrolling now · 3 studies all time

What they study most

COVID-19 Pneumonia, Cytomegalovirus Infection, Relapsed or Refractory Systemic Light Chain Amyloidosis

Studies at this site

• A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age — Stopped early
• Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis — Stopped early
• A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia — Completed